Roche Announces Second Digital Technology Hub in Hyderabad

Roche Holding has officially unveiled plans to establish its second Digital Technology Hub in India, choosing Hyderabad as the strategic location for this major expansion. The new facility, which is scheduled to go live in the first quarter of 2027, will complement the company’s existing technology center in Pune. By situating the new hub in Hyderabad, a city recognized for its thriving life sciences and R&D landscape, Roche aims to accelerate its digital transformation efforts and advance its core mission of improving patient care through data-driven innovation.

Scaling Global Digital Solutions

The Hyderabad Digital Technology Hub will serve as a critical center for delivering IT services and developing digital applications across several key healthcare domains. According to company statements, the facility will house specialized teams focused on biostatistics, enterprise resource planning (ERP), and medical safety.

This expansion is part of Roche’s broader strategy to leverage India’s exceptional talent pool in the intersection of healthcare, data science, and technology. The facility is expected to scale up over the coming years, adding high-end expertise that will support the accelerated development of Roche's global digital healthcare solutions.

Strengthening the Innovation Ecosystem

The choice of Hyderabad underscores the city’s growing stature as a premier destination for global capability centers (GCCs) and advanced technology research. By tapping into the region's vibrant healthcare ecosystem, Roche intends to create scalable innovations that can be deployed across its global operations, which currently serve patients in more than 150 countries.

"Hyderabad is a destination for an exceptional talent pool, especially for the Pharmaceutical and Life Sciences domain," said Ramesh Durvasula, Chief Data Officer and Chief AI Officer at Roche. "By tapping into India’s vibrant healthcare and technology ecosystem, we are creating scalable data-driven innovations to advance our core purpose of improving patient care."

Official Perspectives

Raja Jamalamadaka, Vice-President and Site Head for Roche’s Pune and Hyderabad sites, highlighted that the investment reflects a long-term commitment to the Indian market. "Our investment in Hyderabad—a rapidly growing destination for research, technology, and high-end innovations—reflects our long-term commitment to India and its ecosystem," Jamalamadaka stated. "By scaling our footprint, we are enhancing our capability to orchestrate seamless, next-generation digital and technology solutions."

Why It Matters

For the pharmaceutical and healthcare industry, Roche’s expansion represents a significant shift toward integrating advanced technology directly into the drug development and patient safety lifecycle. The new hub will not only facilitate cost-effective technological scaling but will also integrate specialized domain expertise to bridge the gap between traditional life sciences and modern digital health technologies.

Key Facts at a Glance

• Strategic Location: Hyderabad, India (complementing the existing Pune hub).

• Operational Timeline: Scheduled to go live in the first quarter of 2027.

• Core Functions: IT services, biostatistics, ERP, and medical safety.

• Objective: To scale data-driven healthcare innovation and improve patient outcomes globally.

Frequently Asked Questions

Why did Roche choose Hyderabad for its second hub?

Roche identified Hyderabad for its exceptional talent pool in the pharmaceutical and life sciences domains, as well as its robust technology and research ecosystem.

What services will the Hyderabad hub provide?

The hub will focus on delivering IT services and digital applications, with specific teams working on biostatistics, medical safety, and enterprise resource planning (ERP).

How does this hub fit into Roche’s global network?

It is part of a global technology hub network that supports Roche's pharmaceutical and diagnostic operations in over 150 countries, aiming to accelerate the development of digital healthcare solutions.

Source: Roche Holding, The Economic Times (GCC), Pharmabiz